Workflow
Windtree Therapeutics(WINT) - 2024 Q1 - Quarterly Results

Exhibit 99.1 Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates WARRINGTON, PA – April 17, 2024 – Windtree Therapeutics, Inc. ("Windtree" or "the Company") (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions, today reported financial results for the fourth quarter and fiscal year ended December 31, 2023 and provided key business updates. "The end of 2023 and the past f ...